Healthcare -
Biotechnology - NASDAQ - US
$ 6.42
1.42 %
$ 570 M
Market Cap
-2.73
P/E
VERV - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities VERV - Verve Therapeutics, Inc.
27.7 M
LAST VALUE
45.46%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR